Invention Patent PARTÍCULAS LENTIVIRAIS EXIBINDO MOLÉCULAS DE FUSÃO E USOS DAS MESMAS de UMOJA BIOPHARMA, INC. — IPC A61P 35/00. Drawing published by the INPI in the Industrial Property Gazette.
Examination has not been requested yet. Without that request by 11/03/2026, the application is definitively abandoned (art. 33 of the Brazilian IP Act).
Deadline to request examination:11/03/2026(70 days left)
Latest action published by the INPI: 12/02/2025. We update with every new RPI gazette, published weekly.
São fornecidas na presente invenção partículas compreendendo construtos de polinucleotídeo para gerar células que expressam receptor de antígeno quimérico anti-CD19, assim como vetores, como vetores lentivirais, compreendendo as mesmas, células compreendendo as mesmas e métodos de usar as mesmas.
Prosecution history
Publications in the Brazilian Industrial Property Gazette (RPI).
